Successful Treatment of Dermatomyositis in an Obese Female Patient
Abstract
Dermatomyositis (DM) is a rare autoimmune illness that impacts youngsters and adults and is one of the idiopathic inflammatory myopathies (IIM) with skin involvement and the musculoskeletal system. Systems like, cardiac, respiratory, and gastrointestinal may additionally be affected up to a smaller degree. The predictable occurrence of DM is fewer than 10 cases per million inhabitants. Polymyositis has similar pathogenesis to dermatomyositis particularly targeting the musculoskeletal system without skin involvement.
How to Cite This Article
Banaras F, khan NA, Saifuddin S, Zahid A, Ali Q, Tahir MO. Successful Treatment of Dermatomyositis in an Obese Female Patient. J Pak Soc Intern Med. 2022;3(4):342–344. doi:10.70302/jpsim.v3i4.2268
Conflict of Interest
All authors declare no competing interests.
Funding
No specific funding was received for this research.
Funder information follows the Crossref Funder Registry standard.
References
- Greenberg SA, Amato AA. Inflammatory myopathies. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors Harrison’s principles of internal medicine. 20th ed. New York: McGraw-Hill.
- Bendewald MJ, Wetter DA, Li X, Davis MDP. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population based study in Olmsted county, Minnesota. Arch Dermatol. 2010;146(1):26-30.
- Femia AN. Dermatomyositis. Medscape. [Updated July 2021, Cited October 2022] AVilable from : [https://emedicine.medscape.com/article/332783-overview].
- Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine. 1977;56(4):255-86.
- Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362(9388):971-82.
- Gao X, Han L, Yuan L, Yang Y, Gou G, Sun H et al. HLA class II alleles may influence susceptibility to adult dermatomyositis and polymyositis in a Han Chinese population. BMC Dermatol. 2014;14(1):9.
- Callen JP. Dermatomyositis. Lancet. 2000;355(9197):53-7.
- Kampylafka EI, Kosmidis ML, Panagiotakos DB, Dalakas M, Moutsopoulos HM, Tzioufas AG. The effect of intravenous immunoglobulin (IVIG) treatment on patients with dermatomyositis: a 4-year follow-up study. Clin Exp Rheumatol. 2012;30(3):397-401.
Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.